Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian

Masahiro Yoshikawa1, Kensuke Asaba2, Tomohiro Nakayama1

  • 1Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.

Plos One
|December 13, 2021
PubMed

Insights

Atrial fibrillation may cause chronic kidney disease (CKD), but CKD is unlikely to cause atrial fibrillation. This Mendelian randomization study suggests a causal link between atrial fibrillation and increased CKD risk in Europeans.

Area of Science:

  • Nephrology
  • Cardiology
  • Genetics

Background:

  • Chronic kidney disease (CKD) and atrial fibrillation (AF) are significant global health concerns.
  • Observational studies suggest an association between CKD and AF, but causality is unclear due to potential confounding and reverse causation.

Purpose of the Study:

  • To investigate the causal relationship between CKD and AF using bidirectional two-sample Mendelian randomization.
  • To analyze these associations within the European population.

Main Methods:

  • Utilized publicly available genome-wide association study summary statistics.
  • Employed bidirectional two-sample Mendelian randomization analysis.
  • Included data from the CKDGen consortium and UK Biobank.

Main Results:

  • A causal effect of atrial fibrillation/flutter risk on decreased estimated glomerular filtration rate (eGFR) was suggested.
  • A significant causal effect of atrial fibrillation/flutter risk on the risk of CKD was identified (OR, 9.39; P = 0.001).
  • A causal effect of decreased eGFR on atrial fibrillation/flutter risk was deemed unlikely.

Conclusions:

  • The findings suggest atrial fibrillation may causally increase the risk of developing CKD.
  • The reverse causal pathway from CKD to AF appears unlikely.
  • Further research is needed to understand the underlying mechanisms, and limitations include a relatively small sample size and potential selection bias.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
18
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
188
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
143
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
134
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
80
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
180